Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda
View/ Open
Author
Zelin, Justin
Eziefula, Alice C.
Meyer, Evan C.
Tadesse, Fitsum
Grignard, Lynn
Joice, Regina C.
Drakeley, Chris
Volkman, Sarah K.
Buckee, Caroline
Bousema, Teun
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/srep26330Metadata
Show full item recordCitation
Chang, H., E. Meibalan, J. Zelin, R. Daniels, A. C. Eziefula, E. C. Meyer, F. Tadesse, et al. 2016. “Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda.” Scientific Reports 6 (1): 26330. doi:10.1038/srep26330. http://dx.doi.org/10.1038/srep26330.Abstract
Artemisinin resistance is rapidly spreading in Southeast Asia. The efficacy of artemisinin-combination therapy (ACT) continues to be excellent across Africa. We performed parasite transcriptional profiling and genotyping on samples from an antimalarial treatment trial in Uganda. We used qRT-PCR and genotyping to characterize residual circulating parasite populations after treatment with either ACT or ACT-primaquine. Transcripts suggestive of circulating ring stage parasites were present after treatment at a prevalence of >25% until at least 14 days post initiation of treatment. Greater than 98% of all ring stage parasites were cleared within the first 3 days, but subsequently persisted at low concentrations until day 14 after treatment. Genotyping demonstrated a significant decrease in multiplicity of infection within the first 2 days in both ACT and ACT-primaquine arms. However, multiple clone infections persisted until day 14 post treatment. Our data suggest the presence of genetically diverse persisting parasite populations after ACT treatment. Although we did not demonstrate clinical treatment failures after ACT and the viability and transmissibility of persisting ring stage parasites remain to be shown, these findings are of relevance for the interpretation of parasite clearance transmission dynamics and for monitoring drug effects in Plasmodium falciparum parasites.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873826/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27662278
Collections
- FAS Scholarly Articles [18292]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)